Product
Tradipitant
Aliases
Open Label Tradipitant
10 clinical trials
5 indications
Indication
GastroparesisIndication
Motion SicknessIndication
Healthy VolunteerIndication
Atopic DermatitisIndication
Functional DyspepsiaClinical trial
VP-VLY-686-3301: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Iii Study To Assess The Efficacy Of Tradipitant In Relieving Symptoms Of GastroparesisStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Motion Syros: A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness During TravelStatus: Completed, Estimated PCD: 2023-04-12
Clinical trial
Motion Serifos: A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness During TravelStatus: Recruiting, Estimated PCD: 2024-04-01
Clinical trial
Motion Delos: An Open Label Study to Investigate the Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness During TravelStatus: Recruiting, Estimated PCD: 2025-04-30
Clinical trial
VP-VLY-686-1301: A Single Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation and Gastric Emptying in Healthy VolunteersStatus: Completed, Estimated PCD: 2021-09-24
Clinical trial
VP-VLY-686-3303: Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With GastroparesisStatus:
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Efficacy Study of the Neurokinin-1 Receptor Antagonist VLY-686 in Patients With Atopic DermatitisStatus: Terminated, Estimated PCD: 2020-10-14
Clinical trial
Pharmacodynamics, Pharmacogenetics, Clinical Efficacy and Safety of Tradipitant for Functional DyspepsiaStatus: , Estimated PCD: 2025-12-01
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Efficacy Study of The Neurokinin-1 Receptor Antagonist VLY-686 in Patients With Atopic DermatitisStatus: Completed, Estimated PCD: 2019-12-27
Clinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Tradipitant in Treatment-resistant Pruritus Associated With Atopic DermatitisStatus: Completed, Estimated PCD: 2017-08-04